Form D · Biotechnology

ANESIVA, INC.

South San Francisco, CA · CIK 0001131517

Offering snapshot reported Oct 2, 2009 · SEC filing

Reported sold: $2.2M
Investors reported: 1
Minimum accepted: $0
First sale: May 18, 2009

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$2,000,000 → $2,200,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 2, 2009	Amendment	$2,200,000	$200,000vs Jun 2, 2009	1	SEC filing
Jun 2, 2009	Initial	$2,000,000	No comparison	Not reported	SEC filing
Feb 2, 2009	Initial	$3,000,000	No comparison	Not reported	SEC filing
Oct 21, 2008	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Not reported
Exemptions: 06
Duration over one year: No
Business combination: Yes

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-40517

Source: Form D, filed Oct 2, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Rodney A. Ferguson	Director
John F. Hamilton	Director
William C. Houghton	Executive
Daniel S. Janney	Director
Michael L. Kranda	Director, Executive
Arnold L. Oronsky	Director
Michael F. Powell	Director
John H. Tran	Executive
Jean Frederic Viret	Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:

400 Oyster Point Boulevard, Suite 502
South San Francisco, CA, 94080